Peptide research brief BPC-157: mechanism, in vitro studies, and gaps in human evidence Common name BPC-157 Classification Synthetic peptide fragment (gastric pentadecapeptide) Sequence GEPPPGKPADDAGLV Molecular formula C62H98N16O22 Molecular weight 1419.55 Da CAS 137525-51-0 BPC-157: mechanism, in vitro studies, and gaps in human evidence The proposed bpc-157 mechanism of action centers on a pro-angiogenic signaling cascade reported across rodent and cell-culture experiments, with VEGFR2 receptor activation and downstream endothelial nitric oxide synthase (eNOS) phosphorylation as the most frequently cited nodes (Hsieh et al., 2017
CONCLUSION BPC 157 is a fundamental treatment that quickly restores blood supply to the ischemically injured area and rapidly activates collaterals
In one small study, men who received glutathione before they exercised performed better, felt less fatigued and had lower levels of lactic acid in their blood
It decreases the lesion size of gastric ulcers induced by indomethacin (Cay-70270), aspirin (Cay-70260), or diclofenac (Cay-70680, Cay-22983) in rats at the same doses
Composed of 15 amino acids, it belongs to AXIONs Regenerative System, a research compound cluster organized around signaling pathways associated with tissue integrity and cellular repair
